Follow-Up Recommendations for Non-Suspicious Thyroid Nodules

Initial Follow-Up Schedule

The International Journal of Surgery recommends follow-up ultrasound assessments at 3, 6, and 12 months during the first year for non-suspicious thyroid nodules to establish nodule stability and detect early changes 1

The International Journal of Surgery recommends annual follow-up with ultrasound after the initial 12-month period for benign thyroid nodules to assess changes in nodule characteristics or size 1
The volume reduction rate (VRR) should be calculated at each follow-up using the formula: [(Preoperative nodule volume – current nodule volume) × 100]/preoperative volume (%) for non-suspicious thyroid nodules 1

Nodule size and changes in dimensions should be assessed during follow-up for non-suspicious thyroid nodules 1
Nodule composition (solid, cystic, or mixed) and echogenicity should be evaluated during follow-up for non-suspicious thyroid nodules 2, 3
The presence of new nodules and improvement or worsening of nodule-related symptoms should be assessed during follow-up for non-suspicious thyroid nodules 1
Thyroid function tests should be performed if clinically indicated (e.g., if patient has symptoms of hyper/hypothyroidism) for non-suspicious thyroid nodules 1, 4

Additional evaluation should be considered if the nodule increases in size by ≥3 mm in any dimension for non-suspicious thyroid nodules 5
New suspicious ultrasound features (microcalcifications, irregular margins, hypoechogenicity, taller-than-wide shape) should prompt additional evaluation for non-suspicious thyroid nodules 2, 3
Compressive symptoms (dysphagia, voice changes, difficulty breathing) and cervical lymphadenopathy should prompt additional evaluation for non-suspicious thyroid nodules 1

Routine follow-up may not be necessary in low-risk patients with nodules <6 mm without suspicious features 6
High-risk patients with nodules <6 mm should consider 12-month follow-up, especially if the nodule has suspicious morphology or upper lobe location 6
For multiple nodules, the most suspicious nodule should be used as a guide to management 6

Overdiagnosis and overtreatment of benign thyroid nodules can lead to unnecessary procedures 2
Proceeding directly to radionuclide uptake scan in euthyroid patients is not recommended and has low diagnostic value 4
Using radionuclide scanning to determine malignancy in euthyroid patients with nodules is not recommended 4
Failing to check TSH levels before selecting an imaging modality can lead to unnecessary testing 4

TSH measurement should be performed if clinically indicated for non-suspicious thyroid nodules 3, 4
Regular monitoring of thyroid function tests is recommended for patients with previously abnormal thyroid function 1
Thyroid function tests (TSH, fT3, fT4) should be performed at each follow-up until normal function is restored for autonomously functioning nodules 1